Marshall Wace, LLP Orchard Therapeutics PLC Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $16,482 - $35,555	-23,547 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $155,030 - $298,032	-133,647 Reduced 85.02%	23,547 $31,000
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $352,114 - $674,362	157,194 New	157,194 $361,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $272,998 - $428,428	-66,423 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$5.75 - $11.99 $381,932 - $796,411	66,423 New	66,423 $399,000
Q1 2020 May 15, 2020	SELL	$5.65 - $15.71 $784,389 - $2.18 Million	-138,830 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $1.12 Million - $1.72 Million	110,707 Added 393.65%	138,830 $1.91 Million
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $34,998 - $49,257	2,946 Added 11.7%	28,123 $334,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $332,336 - $519,401	25,177 New	25,177 $352,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.